RT Journal Article
SR Electronic
T1 A Methodological Review of Patient Healthcare-Seeking Journeys from Symptom Onset to Receipt of Care
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.08.01.24311159
DO 10.1101/2024.08.01.24311159
A1 Oga-Omenka, Charity
A1 Sassi, Angelina
A1 Vasquez, Nathaly Aguilera
A1 Rana, Namrata
A1 Essar, Mohammad Yasir
A1 Ku, Darryl
A1 Diploma, Hanna
A1 Huria, Lavanya
A1 Saqib, Kiran
A1 Das, Rishav
A1 Stallworthy, Guy
A1 Pai, Madhukar
YR 2024
UL http://medrxiv.org/content/early/2024/08/02/2024.08.01.24311159.abstract
AB Background For many diseases, early diagnosis and treatment are more cost-effective, reduce community spread of infectious diseases, and result in better patient outcomes. However, healthcare-seeking and diagnoses for several diseases are unnecessarily delayed. For example, in 2022, 3 million and 5.6 million people living with TB and HIV respectively were undiagnosed. Many patients never access appropriate testing, remain undiagnosed after testing or drop out shortly after treatment initiation. This underscores challenges in accessing healthcare for many individuals. Understanding healthcare-seeking obstacles can expose bottlenecks in healthcare delivery and promote equity of access. We aimed to synthesize methodologies used to portray healthcare-seeking trajectories and provide a conceptual framework for patient journey analyses.Design/Methods We conducted a literature search using keywords related to “patient/care healthcare-seeking/journey/pathway analysis” AND “TB” OR “infectious/pulmonary diseases” in PubMED, CINAHL, Web of Science and Global Health (OVID). From a preliminary scoping search and expert consultation, we developed a conceptual framework and honed the key data points necessary to understand patients’ healthcare-seeking journeys, which then served as our inclusion criteria for the subsequent expanded review. Retained papers included at least three of these data points.Results Our conceptual framework included 5 data points and 7 related indicators that contribute to understanding patients’ experiences during healthcare-seeking. We retained 66 studies that met our eligibility criteria. Most studies (56.3%) were in Central and Southeast Asia, explored TB healthcare-seeking experiences (76.6%), were quantitative (67.2%), used in-depth, semi-structured, or structured questionnaires for data collection (73.4%). Healthcare-seeking journeys were explored, measured and portrayed in different ways, with no consistency in included information.Conclusions We synthesized various methodologies in exploring patient healthcare-seeking journeys and found crucial data points necessary to understand challenges patients encounter when interacting with health systems. and offer insights to researchers and healthcare practitioners. Our framework proposes a standardized approach to patient journey research.What is already known about this subject?Accessing healthcare is challenging for half of the world’s population.Understanding healthcare-seeking obstacles can help to expose bottlenecks in healthcare delivery and improve access.What does this study add?We synthesized the different methodologies used by researchers to portray healthcare- seeking trajectories.We also provide a conceptual framework and recommendations for patient journey analyses.How do the new findings imply?Our analysis revealed a lack of consistency in how patient journeys to care are represented and a notable complexity in generating insightful depictions of journeys to care.The use of our conceptual framework, namely the data points and indicators, could increase the reliability and generalisability patient journey analyses.Competing Interest StatementGS, a co-author of this manuscript and an employee of the BMGF provided valuable inputs on the study design, analysis, and revision of the manuscript. MP serves as an advisor to several non-profit organizations including Bill & Melinda Gates Foundation, WHO, Stop TB Partnership and FIND. He has no financial or industry conflicts. All other authors declare no conflicts of interest.Funding StatementThis work was supported by the McGill International TB Centre with funding from the Bill & Melinda Gates Foundation (BMGF) [grant number INV-022420], and by the School of Public Health Sciences, University of Waterloo. MP was also supported by a Canada Research Chair award from the Canadian Institutes of Health Research (CIHR).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript